Defibrillator Icd Articles & Analysis
6 news found
Longer-term follow up results from the MODERATO II study presented at the American College of Cardiology conference in May 2021, but not included in JAHA publication, showed that BackBeat CNT reduced oSBP in treated ISH patients by an average of 16.4 mmHg after 18 months of treatment. 1BIS Research, 2017, Global Pacemaker and Implantable Cardioverter Defibrillators ...
Today, most people with VT are treated with implantable cardioverter defibrillators (ICDs), which monitor the heart rhythm and deliver a strong shock to the heart muscle to correct irregular pacing. However, ICDs don’t halt the disease’s progression, and the repeated shocks can be painful. ...
WALTHAM. Mass.. May 19,2020 - Thermedicak a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT): today announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate® catheter. The FDA Breakthrough Devices Program is intended to help ...
WALTHAM, Mass., May 8, 2020 - Thermedicak a developer of thermal-ablation systems to treat ventricular tachycardia (VT), announced that results from a First-in-Human Early Feasibility Study (EFS) using the new Durablate® catheter to treat VT were presented in the late-breaking clinical trial sessions at the Heart Rhythm Society (HRS) meeting today. Called the Saline Enhanced Radiofrequency ...
The WiSE system works together with a previously implanted pacemaker or implantable cardioverter defibrillator (ICD) that paces the right side of the heart. “Wireless pacing promises to address an important unmet need for patients with heart failure. ...
CHICAGO, May 12, 2017 - A new study examines the effectiveness of the Implantable Subcutaneous String Defibrillator (ISSD™), a flexible, string-shaped and first-ever rechargeable implantable cardioverter-defibrillator (ICD). ...